Generics manufacturer Zentiva becomes an independent organization

Patrick Aghanian, Head of Zentiva, believes that the divestment brings new opportunities for the company and its customers, resulting in a faster, more flexible and more agile business.

"Zentiva's roots reach back 530 years to the Black Eagle pharmacy, a small business on the castle side of Prague. We are very proud of our roots and heritage and we look forward to expanding and building our footprint in Generics and OTC medicines across Europe. This heritage not only strengthens our resolve to remain customer-focused, it also drives our future priorities as we strive to improve healthcare with a more personalized approach. It is our aspiration that healthcare should be a right and not a privilege, and that healthcare solutions should be accessible to as many people as possible."

"We want to build a reputation that is recognized by our partners as being synonymous with value" he continues. "Standing side-by-side with healthcare professionals, pharmacists and Health System decision-makers, we have the same sense of social obligation to help lower costs and improve access to healthcare. We strive to support people's daily healthcare needs."

Patrick adds that this latest chapter in the company's history is also positive news for employees:

The intended growth of our organization brings new opportunities for our people to fulfill their potential. It also positions us well to attract the best talent and retain our team to secure our success for future generations. This is an exciting time for Zentiva and we are confident that with the support of Advent we can realize our ambition."